Vertebral Fracture and Cortical Bone Changes in Corticosteroid-Induced Osteoporosis

被引:0
|
作者
H. Tsugeno
H. Tsugeno
T. Fujita
B. Goto
T. Sugishita
Y. Hosaki
K. Ashida
F. Mitsunobu ,
Y. Tanizaki
Y. Shiratori
机构
[1] Department of Medicine,
[2] Misasa Medical Center,undefined
[3] Okayama University Medical School,undefined
[4] Tottori,undefined
[5] Calcium Research Institute,undefined
[6] Osaka,undefined
[7] Third Division,undefined
[8] Department of Medicine,undefined
[9] Kobe University School of Medicine,undefined
[10] Hyogo;,undefined
[11] Department of Medicine and Medical Science,undefined
[12] Okayama University Graduate School of Medicine and Dentistry,undefined
[13] Okayama,undefined
[14] Japan,undefined
来源
关键词
Key words:Cortical bone – Corticosteroid, Peripheral quantitative computed tomography – Vertebral fracture;
D O I
暂无
中图分类号
学科分类号
摘要
Despite an intriguing understanding of trabecular bone dynamics, little is known about corticosteroid-induced cortical bone loss and fractures. Recently, we verified a steroid-induced decrease in cortical bone volume and density using peripheral quantitative computed tomography (pQCT) in adult asthmatic patients given oral corticosteroids. Subsequently, the pQCT parameters and presence of vertebral fractures were investigated to further clarify the role of cortical bone quality in fractures in 86 postmenopausal (>5 years after menopause) asthmatic patients on high-dose oral steroid (>10 g cumulative oral prednisolone) (steroid group) and 194 age-matched controls (control group). Cortical and trabecular bone was subjected to measurement of various parameters using pQCT (Stratec XCT960). Relative Cortical Volume (RCV) was calculated by dividing the cortical area by the total bone area. Strength Strain Index (SSI) was determined in the radius based on the density distribution around the axis. Spinal fracture was assessed on lateral radiographs. Patients treated with high doses of oral steroid (>10 g cumulative oral prednisolone) were found to have an increased risk of fracture compared with control women receiving no steroid medication (odds ratio, 8.85; 95% CI, 4.21–18.60) after adjustment was made for years since menopause, body mass index and RCV. In both groups, the diagnostic and predictive ability of the pQCT parameters for vertebral fracture was assessed by the areas under their receiver operating characteristic (ROC) curves. All parameters were found to be significant predictors (p<0.0001) in the control group. In the steroid group, however, the cortical bone mineral density (BMD) (p= 0.001), RCV (p<0.0001) and SSI (p= 0.001) were found to be significant predictors, but not trabecular BMD (p= 0.176). For comparison between the two groups, thresholds of all parameters for vertebral fracture were also calculated by the point of coincidence of sensitivity with specificity in ROC testing and the 90th percentile value. Although a rise in fracture threshold in the steroid group was suggested, considerable difference in the values obtained by the two methods of calculation precluded any conclusion. High-dose oral steroid administration was associated with an increased risk of fracture. Cortical bone parameters obtained by pQCT could play a role as good predictors of future corticosteroid-induced vertebral fractures.
引用
下载
收藏
页码:650 / 656
页数:6
相关论文
共 50 条
  • [21] Corticosteroid-induced osteoporosis - Reply
    Erb, N
    Duncan, R
    Raza, K
    Rowe, IF
    Kitas, GD
    Situnayake, RD
    RHEUMATOLOGY, 2003, 42 (09) : 1120 - 1120
  • [22] MANAGEMENT OF CORTICOSTEROID-INDUCED OSTEOPOROSIS
    EASTELL, R
    JOURNAL OF INTERNAL MEDICINE, 1995, 237 (05) : 439 - 447
  • [23] Management of corticosteroid-induced osteoporosis
    Adachi, JD
    Olszynski, WP
    Hanley, DA
    Hodsman, AB
    Kendler, DL
    Siminoski, KG
    Brown, J
    Cowden, EA
    Goltzman, D
    Ioannidis, G
    Josse, RG
    Ste-Marie, LG
    Tenenhouse, AM
    Davison, KS
    Blocka, KLN
    Pollock, AP
    Sibley, J
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2000, 29 (04) : 228 - 251
  • [24] Corticosteroid-induced osteoporosis halted
    Frankel, DH
    LANCET, 1997, 350 (9076): : 496 - 496
  • [25] Corticosteroid-induced osteoporosis and fractures
    Romas, Evange
    AUSTRALIAN PRESCRIBER, 2008, 31 (02) : 45 - 49
  • [26] Prevention of corticosteroid-induced osteoporosis
    Birdsall, TC
    ANNALS OF INTERNAL MEDICINE, 1997, 127 (01) : 90 - 90
  • [27] Epidemiology of corticosteroid-induced osteoporosis
    Braun, J
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2001, 60 (02): : 107 - 110
  • [28] Management of corticosteroid-induced osteoporosis
    Stevenson, JC
    LANCET, 1998, 352 (9137): : 1327 - 1328
  • [29] Risk of corticosteroid-induced osteoporosis
    McLellan, A
    HOSPITAL MEDICINE, 1998, 59 (05): : 416 - 417
  • [30] Prevention of corticosteroid-induced osteoporosis
    AscottEvans, BH
    SOUTH AFRICAN MEDICAL JOURNAL, 1996, 86 (08): : 1025 - 1026